Location History:
- Ichikawa, JP (1985)
- Kawasaki, JP (1992 - 1993)
Company Filing History:
Years Active: 1985-1993
Title: Innovator Kiyoto Imae: A Pioneer in Antibiotic Development
Introduction: Kiyoto Imae, an accomplished inventor based in Kawasaki, Japan, has made significant contributions to the field of antibiotic research. With a total of five patents to his name, Imae's work has been instrumental in the development of new cephalosporin compounds, which are vital in combating bacterial infections.
Latest Patents: Kiyoto Imae's most recent patents include innovative antibiotic compounds. His first patent is for antibiotic C-7 catechol-substituted cephalosporin compounds, which relate to new cephalosporins of a specific chemical formula, wherein R¹ and R² can be hydrogen or carboxy with the condition that both cannot be identical. The second patent focuses on antibiotic C-3 di-hydroxyphenyl substituted cephalosporin compounds, also outlining a new cephalosporin structure where Y can be either N or CH. These advancements highlight Imae's commitment to enhancing antibiotic efficacy.
Career Highlights: Throughout his career, Kiyoto Imae has worked for prominent companies in the pharmaceutical industry, including Bristol-Myers Squibb Company and Bristol-Myers Company. His tenure at these organizations has allowed him to engage in groundbreaking research and development in antibiotic formulations.
Collaborations: Imae has collaborated with notable coworkers, including Hajime Kamachi and Takaaki Okita. Together, they have contributed to various projects, leveraging their collective expertise in pharmaceutical sciences.
Conclusion: Kiyoto Imae's innovative work in the field of antibiotics showcases his dedication to improving public health through scientific advancements. His five patents stand as a testament to his role as a pioneer in antibiotic development, influencing the future of medicine and bacteriology.